Researchers have identified a protein that powers the virulence of the bacteria that causes gonorrhea, opening the possibility of a new target for antibiotics and, even better, a vaccine.
The findings, published today in PLOS Pathogens, are especially important since the microbe, Neisseria gonorrhoeae, is considered a “superbug” because of its resistance to all classes of antibiotics available for treating infections.
Gonorrhea, a sexually transmitted disease that results in 78 million new cases worldwide each year, is highly damaging if untreated or improperly treated.
It can lead to endometritis, pelvic inflammatory disease, ectopic pregnancy, epididymitis and infertility. Babies born to infected mothers are at increased risk of blindness.
“The infections very often are silent,” said Oregon State University researcher Aleksandra Sikora. “Up to 50 percent of infected women don’t have symptoms, but those asymptomatic cases can still lead to some very severe consequences for the patient’s reproductive health, miscarriage or premature delivery.”
The need for better antibiotic therapy, and a vaccine, is pressing. N. gonorrhoeae strains resistant to the last effective treatment options have emerged, and failures in treatment are occurring.
Sikora and her research team at the OSU/OHSU College of Pharmacy and Ann Jerse’s lab at the Uniformed Services University of the Health Sciences in Bethesda, Maryland, collaborated to discover a novel lipoprotein that N. gonorrhoeae uses to defeat the body’s first line of innate immune defense.
The body relies on enzymes known as lysozymes that, as their name suggests, thwart bacteria by causing their cell wall to lyse, or break apart. Lysozymes are abundant both in epithelial cells, which make up the tissue on the outside of organs and the inside of body cavities, and in the phagocytic cells that protect the body by ingesting foreign particles and bacteria.
In turn, many gram-negative bacteria – characterized by their cell envelope that includes a protective outer membrane – have developed ways of defeating lysozymes. Prior to the work by Sikora’s team, however, only one lysozyme-fighting protein had been discovered in the Neisseria genus.
Now that new targets have been identified, they can be explored as bullseye candidates for new antibiotics or a vaccine – if the lysozyme inhibitor can itself be inhibited, then the bacteria’s infection-causing ability is greatly reduced.
Sikora and her collaborators named the new protein SliC, short for surface-exposed lysozyme inhibitor of c-type lysozyme.
Studying SliC’s function in culture as well as in a gonorrhea mouse model – mice were infected with N. gonorrhoeae, then checked for SliC expression at one, three and five days – researchers determined the protein was essential to bacterial colonization because of its anti-lysozyme role.
“This is the first time an animal model has been used to demonstrate a lysozyme inhibitor’s role in gonorrhea infection,” Sikora said. “Together, all of our experiments show how important the lysozyme inhibitor is. This is very exciting.”
The Latest on: Gonorrhea
via Google News
The Latest on: Gonorrhea
- Rise in rare, severe gonorrhea complications concerns California health officialson November 21, 2020 at 12:39 pm
The California Department of Public Health has received several reports of disseminated gonococcal infections.
- California Doctors Report Increase In Rare STD Complications Amid COVID-19 Pandemicon November 20, 2020 at 2:42 pm
Health officials say they are seeing an increase in rare and severe complications from untreated gonorrhea in recent months.
- California Health Officials Concerned Over Rise in Severe Gonorrhea Caseson November 20, 2020 at 1:49 pm
State health officials warned Friday that doctors are seeing increasing cases of a severe form of gonorrhea across the state, which they blame on patients not seeking treatment.
- California sees increase in rare, 'severe complications' from untreated gonorrheaon November 20, 2020 at 1:24 pm
The California Department of Public Health sent out a release Friday sounding the alarm not on COVID-19 this time, but about a "significant complication" of a sexually transmitted disease.
- California sees increase in untreated gonorrhea caseson November 20, 2020 at 12:29 pm
The California Department of Public Health announced Friday it has received reports of an increase in rare, severe complications from untreated gonorrhea. According to health officials, a severe form ...
- California seeing a rare spike in symptoms of an old, treatable disease: gonorrheaon November 20, 2020 at 4:43 am
As STDs rise, state public health officials have a message for key groups of sexually active people: Get tested for gonorrhea.
- Gonorrhea infections increasing in Michigan: officialson November 19, 2020 at 6:28 am
Gonorrhea infections are increasing in Michigan, according to state health officials. By the end of October, cases of gonorrhea, a sexually transmitted disease (STD), had surpassed those reported in ...
- State officials: Gonorrhea infections on pace to rise 22% over 2019on November 18, 2020 at 4:27 pm
Gonorrhea infections are on the rise in Michigan, state officials said Tuesday. As of Oct. 31, this year's cases of the sexually transmitted disease in the state have surpassed 2019's total of ...
- Michigan sees significant increase in number of reported gonorrhea infectionson November 17, 2020 at 1:23 pm
There has been a significant increase in the number of reported gonorrhea infections in across the state, the Michigan Department of Health and Human Services said.
via Bing News